News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community | Unity Walk in the Media

Kyowa Kirin Announces FDA Reviewing New Drug Application for Istradefylline

April 4, 2019 –The FDA is reviewing the resubmitted New Drug Application for istradefylline. This investigational selective adenosine A 2A receptor antagonist could be used during “OFF” episodes as an adjunct to levodopa/carbidopa  in adults with Parkinson’s disease (PD).  
Read more